All marketing authorization holders of medicine are hereby informed that black warning as "NOT TO USE IN ASTHMA" should be included in labels of Glycopyrronium 12.5mcg + Formeterol fumarate dihydrate 12mcg + Fluticasone propinate 250mcg powder for inhalation in three language and to consider it as schedule IIC medicine.

‍

(Date: 07 September 2022)